ID

44001

Descrizione

Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis; ODM derived from: https://clinicaltrials.gov/show/NCT00029107

collegamento

https://clinicaltrials.gov/show/NCT00029107

Keywords

versioni (2)
  1. 08/07/16 08/07/16 -
  2. 20/09/21 20/09/21 -
Caricato su

20 settembre 2021

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Hepatitis C NCT00029107

Inglese

Eligibility Hepatitis C NCT00029107

1 moduli  
Criteria
Descrizione

Criteria

diagnosis of hcv-cv: must have all of the following
Descrizione

diagnosis of hcv-cv

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019196
hcv infection documented by serology and/or plasma hcv rna.
Descrizione

hcv rna- or seropositive

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1269695
UMLS CUI [2]
C0855842
one or more organ system with objective evidence of active vasculitis such as:
Descrizione

active vasculitis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0042384
palpable purpura
Descrizione

palpable purpura

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0151190
glomerulonephritis (defined by the presence of glomerular hematuria and/or new or worsening proteinuria);
Descrizione

glomerulonephritis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0017658
acute peripheral neuropathy.
Descrizione

acute peripheral neuropathy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0031117
detectable cryoglobulins and/or rf.
Descrizione

detectable cryoglobulins or rheumatoid factors

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0392385
UMLS CUI [2]
C0151379
failure of treatment with ifn-alpha and ribavirin to control manifestations of hcv-cv or intolerance to ifn-alpha/ribavirin regimen.
Descrizione

cytostatic treatment failure

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0162643
UMLS CUI [1,2]
C0002199
UMLS CUI [2,1]
C0162643
UMLS CUI [2,2]
C0035525
patients must have a personal physician responsible for the care of their hcv.
Descrizione

personal physician

Tipo di dati

boolean

ages of 18 and 75 years
Descrizione

age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
willingness to use effective contraception during and for 12 months following rituximab treatment. effective contraception methods include abstinence, surgical sterilization of either partner, barrier methods such as diaphragm, condom, cap or sponge, or hormonal contraception.
Descrizione

contraceptive methods

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0700589
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
recent (within 4 weeks) initiation of or increase in immunosuppressive therapy.
Descrizione

immunosuppressive therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021079
active systemic infection (other than hepatitis c).
Descrizione

active systemic infection

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009450
pregnancy or breast feeding.
Descrizione

pregnancy or breast feeding

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0006147
prior treatment with rituximab.
Descrizione

prior treatment with rituximab

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0393022
known allergy to murine proteins.
Descrizione

allergy to murine proteins

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1699668
significant renal insufficiency (creatinine clearance less than 30 ml/min).
Descrizione

renal insufficiency

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1565489
presence of life-threatening hcv-cv; defined as rapidly progressive glomerulonephritis (defined as a doubling of the serum creatinine over a 3 month period), cns vasculitis, cardiac disease due to active vasculitis, or gi vasculitis (defined by ischemic bowel, perforation, or infarction).
Descrizione

life-threatening hcv-cv

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0221239
UMLS CUI [2]
C0042384
UMLS CUI [3]
C0856069
significant hepatic insufficiency as manifested by child-pugh classification of b or c.
Descrizione

hepatic insufficiency

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1306571
UMLS CUI [1,2]
C4050412
history of variceal bleeding, encephalopathy.
Descrizione

variceal bleeding or encephalopathy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1739112
UMLS CUI [2]
C0085584
history of liver transplantation.
Descrizione

history of liver transplantation.

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0023911
co-infection with either hbv or hiv.
Descrizione

co-infection with either hbv or hiv

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2242656
UMLS CUI [2]
C4062778
any underlying medical condition that in the judgment of the investigator would put the patient at increased risk for serious infusion-related adverse events.
Descrizione

any condition compromising study protocol compliance

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0009488
Ritorna all'inizio della pagina

Similar models

Eligibility Hepatitis C NCT00029107

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
diagnosis of hcv-cv
Item
diagnosis of hcv-cv: must have all of the following
boolean
C0019196 (UMLS CUI [1])
hcv rna- or seropositive
Item
hcv infection documented by serology and/or plasma hcv rna.
boolean
C1269695 (UMLS CUI [1])
C0855842 (UMLS CUI [2])
active vasculitis
Item
one or more organ system with objective evidence of active vasculitis such as:
boolean
C0042384 (UMLS CUI [1])
palpable purpura
Item
palpable purpura
boolean
C0151190 (UMLS CUI [1])
glomerulonephritis
Item
glomerulonephritis (defined by the presence of glomerular hematuria and/or new or worsening proteinuria);
boolean
C0017658 (UMLS CUI [1])
acute peripheral neuropathy
Item
acute peripheral neuropathy.
boolean
C0031117 (UMLS CUI [1])
detectable cryoglobulins or rheumatoid factors
Item
detectable cryoglobulins and/or rf.
boolean
C0392385 (UMLS CUI [1])
C0151379 (UMLS CUI [2])
cytostatic treatment failure
Item
failure of treatment with ifn-alpha and ribavirin to control manifestations of hcv-cv or intolerance to ifn-alpha/ribavirin regimen.
boolean
C0162643 (UMLS CUI [1,1])
C0002199 (UMLS CUI [1,2])
C0162643 (UMLS CUI [2,1])
C0035525 (UMLS CUI [2,2])
personal physician
Item
patients must have a personal physician responsible for the care of their hcv.
boolean
age
Item
ages of 18 and 75 years
boolean
C0001779 (UMLS CUI [1])
contraceptive methods
Item
willingness to use effective contraception during and for 12 months following rituximab treatment. effective contraception methods include abstinence, surgical sterilization of either partner, barrier methods such as diaphragm, condom, cap or sponge, or hormonal contraception.
boolean
C0700589 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
immunosuppressive therapy
Item
recent (within 4 weeks) initiation of or increase in immunosuppressive therapy.
boolean
C0021079 (UMLS CUI [1])
active systemic infection
Item
active systemic infection (other than hepatitis c).
boolean
C0009450 (UMLS CUI [1])
pregnancy or breast feeding
Item
pregnancy or breast feeding.
boolean
C0032961 (UMLS CUI [1,1])
C0006147 (UMLS CUI [1,2])
prior treatment with rituximab
Item
prior treatment with rituximab.
boolean
C1514463 (UMLS CUI [1,1])
C0393022 (UMLS CUI [1,2])
allergy to murine proteins
Item
known allergy to murine proteins.
boolean
C0020517 (UMLS CUI [1,1])
C1699668 (UMLS CUI [1,2])
renal insufficiency
Item
significant renal insufficiency (creatinine clearance less than 30 ml/min).
boolean
C1565489 (UMLS CUI [1])
life-threatening hcv-cv
Item
presence of life-threatening hcv-cv; defined as rapidly progressive glomerulonephritis (defined as a doubling of the serum creatinine over a 3 month period), cns vasculitis, cardiac disease due to active vasculitis, or gi vasculitis (defined by ischemic bowel, perforation, or infarction).
boolean
C0221239 (UMLS CUI [1])
C0042384 (UMLS CUI [2])
C0856069 (UMLS CUI [3])
hepatic insufficiency
Item
significant hepatic insufficiency as manifested by child-pugh classification of b or c.
boolean
C1306571 (UMLS CUI [1,1])
C4050412 (UMLS CUI [1,2])
variceal bleeding or encephalopathy
Item
history of variceal bleeding, encephalopathy.
boolean
C1739112 (UMLS CUI [1])
C0085584 (UMLS CUI [2])
history of liver transplantation.
Item
history of liver transplantation.
boolean
C0262926 (UMLS CUI [1,1])
C0023911 (UMLS CUI [1,2])
co-infection with either hbv or hiv
Item
co-infection with either hbv or hiv.
boolean
C2242656 (UMLS CUI [1])
C4062778 (UMLS CUI [2])
any condition compromising study protocol compliance
Item
any underlying medical condition that in the judgment of the investigator would put the patient at increased risk for serious infusion-related adverse events.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial